Literature DB >> 2740080

Long-term follow-up of idiopathic central serous chorioretinopathy by fluorescein angiography.

R Levine1, A J Brucker, F Robinson.   

Abstract

Idiopathic central serous chorioretinopathy (ICSC) is typically described as a self-limited, unilateral disease that affects healthy, young adult males. The authors studied 13 patients (14 eyes) who had documented spontaneous resolution of symptomatic macular detachments. These patients were evaluated in a longitudinal fashion to determine the fate of the retinal pigment epithelium (RPE) as viewed angiographically, both in the initially affected eyes and the fellow eyes. At the time of follow-up examination of the initially affected eyes, nonleaking RPE defects had developed inside the areas of previous serous detachment in all cases. Nonleaking RPE defects had developed outside these areas in six (43%) eyes. Two (14%) eyes had new, asymptomatic macular detachments. Six (42%) fellow eyes had new RPE window defects; two (17%) of them also had active RPE dye leakage resulting in asymptomatic macular detachment at the final examination. Four (29%) originally involved eyes and one (8%) fellow eye lost more than two lines of Snellen visual acuity during the follow-up period. The authors' results suggest that ICSC may be a progressive bilateral disease that develops asymmetrically and causes diffuse RPE changes not localized to the area of serous detachment. Long-term follow-up of these patients may, therefore, be advisable.

Entities:  

Mesh:

Year:  1989        PMID: 2740080     DOI: 10.1016/s0161-6420(89)32810-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  46 in total

1.  Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.

Authors:  Serra Arf; Mumin Hocaoglu; Isil Sayman Muslubas; Murat Karacorlu
Journal:  Int Ophthalmol       Date:  2016-07-08       Impact factor: 2.031

Review 2.  Molecular contrast optical coherence tomography: a review.

Authors:  Changhuei Yang
Journal:  Photochem Photobiol       Date:  2005 Mar-Apr       Impact factor: 3.421

3.  Imaging polarimetry in central serous chorioretinopathy.

Authors:  Masahiro Miura; Ann E Elsner; Anke Weber; Michael C Cheney; Masahiro Osako; Masahiko Usui; Takuya Iwasaki
Journal:  Am J Ophthalmol       Date:  2005-12       Impact factor: 5.258

4.  Transpupillary thermotherapy for chronic central serous chorioretinopathy.

Authors:  Nazimul Hussain; Rohit Khanna; Anjli Hussain; Taraprasad Das
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

5.  Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: long-term follow-up.

Authors:  A Arsan; H S Kanar; A Sonmez
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

6.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

Review 7.  Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis.

Authors:  H Q Lu; E Q Wang; T Zhang; Y X Chen
Journal:  Eye (Lond)       Date:  2015-10-30       Impact factor: 3.775

8.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level.

Authors:  W-M Chan; D S C Lam; T Y Y Lai; B S M Tam; D T L Liu; C K M Chan
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

9.  The effect of intravitreal bevacizumab in patients with acute central serous chorioretinopathy.

Authors:  Ji Won Lim; Su Jeong Ryu; Min Cheol Shin
Journal:  Korean J Ophthalmol       Date:  2010-06-05

10.  Central serous chorioretinopathy in African Americans.

Authors:  Uday R Desai; Amir A Alhalel; Thomas J Campen; Rhett M Schiffman; Paul A Edwards; Gordon R Jacobsen
Journal:  J Natl Med Assoc       Date:  2003-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.